Abstract:. Swim up semen preparation technique was used in all cases. Insemination was performed in both groups 34e37 h after hCG administration. Standard IUI was performed using 0.5 ml of inseminate. In FSP 4 ml inseminate was used. Results: In group A (184 IUI cycles in 100 patients), 22 clinical pregnancies (presence of gestational sac with fetal cardiac activity) occurred (11.95% per cycle over four cycles). In group B, (220 cycles of FSP in 100 patients), 48 clinical pregnancies occurred (21.81% per cycle over fou… Show more
“…After insemination the luteal phase was supported in all participants by daily vaginal supplementation of 400 mg micronized progesterone until day of HCG test performed 14 days after insemination. The end point of the treatment cycle was either a negative pregnancy test or a positive test (serum b-HCG) confirmed by clinical evidence of pregnancy in the form of intrauterine gestational sac and fetal heart pulsation by TVS 2 weeks after positive pregnancy test [8].…”
Section: Luteal Supportmentioning
confidence: 99%
“…Only a median of 251 spermatozoa were recorded by flushing the tubes [4] and there was only a 49% chance of peritoneal spermatozoa to be found even when all semen characteristics were normal [5]. Many methods have been tried to improve the outcome of IUI including certain ovarian stimulation with improvement of pregnancy rate [2], perturbation 1 day before IUI [3] but Aboulghar et al [6] found no significant difference in pregnancy rate with and without hydrotubation before IUI, Fallopian tube sperm perfusion (FSP) [7,8] and intrauterine tuboperitoneal insemination (IUTPI) [9] using 4 ml and 10 ml inseminate respectively. Four milliliters of inseminate carrying spermatozoa were not sufficient to fill the uterus and Fallopian tubes and did not reach the pouch of Douglas.…”
Objective:• To compare the cycle pregnancy rate of intrauterine insemination (IUI) to that of intrauterine tuboperitoneal insemination (IUTPI) in unexplained infertility. • To assess the effect of timing of insemination in relation to ovulation on the cycle pregnancy rate of IUI and IUTPI.
“…After insemination the luteal phase was supported in all participants by daily vaginal supplementation of 400 mg micronized progesterone until day of HCG test performed 14 days after insemination. The end point of the treatment cycle was either a negative pregnancy test or a positive test (serum b-HCG) confirmed by clinical evidence of pregnancy in the form of intrauterine gestational sac and fetal heart pulsation by TVS 2 weeks after positive pregnancy test [8].…”
Section: Luteal Supportmentioning
confidence: 99%
“…Only a median of 251 spermatozoa were recorded by flushing the tubes [4] and there was only a 49% chance of peritoneal spermatozoa to be found even when all semen characteristics were normal [5]. Many methods have been tried to improve the outcome of IUI including certain ovarian stimulation with improvement of pregnancy rate [2], perturbation 1 day before IUI [3] but Aboulghar et al [6] found no significant difference in pregnancy rate with and without hydrotubation before IUI, Fallopian tube sperm perfusion (FSP) [7,8] and intrauterine tuboperitoneal insemination (IUTPI) [9] using 4 ml and 10 ml inseminate respectively. Four milliliters of inseminate carrying spermatozoa were not sufficient to fill the uterus and Fallopian tubes and did not reach the pouch of Douglas.…”
Objective:• To compare the cycle pregnancy rate of intrauterine insemination (IUI) to that of intrauterine tuboperitoneal insemination (IUTPI) in unexplained infertility. • To assess the effect of timing of insemination in relation to ovulation on the cycle pregnancy rate of IUI and IUTPI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.